Literature DB >> 7699055

Subtyping of hepatitis C virus isolates by a line probe assay using hybridization.

A Andonov1, R K Chaudhary.   

Abstract

A reverse hybridization test (Inno-LiPA HCV; Innogenetics, N.V., Zwijnaarde, Belgium) was used for typing hepatitis C virus. All 38 samples, typed by PCR with primers from core and NS5 genes, were also genotyped by this test. Of the samples, 33 (87%) had the same subtypes by both assays. The correlations between PCR and Inno-LiPA for individual types were 77% for type I (1a), 90% for type II (1b), 100% for type III (2a), 100% for type IV (2b), and 100% for type V (3a). One of the type III (2a) samples also reacted with type I (1a) probes in the Inno-LiPA test.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699055      PMCID: PMC227924          DOI: 10.1128/jcm.33.1.254-256.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  HCV genotypes in chronic hepatitis C and response to interferon.

Authors:  K Kanai; M Kako; H Okamoto
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Typing of hepatitis C virus genomes by restriction fragment length polymorphism.

Authors:  T Nakao; N Enomoto; N Takada; A Takada; T Date
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

4.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  Differences in the hepatitis C virus genotypes in different countries.

Authors:  N Takada; S Takase; A Takada; T Date
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

6.  At least five related, but distinct, hepatitis C viral genotypes exist.

Authors:  T A Cha; E Beall; B Irvine; J Kolberg; D Chien; G Kuo; M S Urdea
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

Authors:  L Stuyver; R Rossau; A Wyseur; M Duhamel; B Vanderborght; H Van Heuverswyn; G Maertens
Journal:  J Gen Virol       Date:  1993-06       Impact factor: 3.891

8.  Genotyping of Canadian hepatitis C virus isolates by PCR.

Authors:  A Andonov; R K Chaudhary
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

9.  Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.

Authors:  F McOmish; S W Chan; B C Dow; J Gillon; W D Frame; R J Crawford; P L Yap; E A Follett; P Simmonds
Journal:  Transfusion       Date:  1993-01       Impact factor: 3.157

10.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

Authors:  H Okamoto; Y Sugiyama; S Okada; K Kurai; Y Akahane; Y Sugai; T Tanaka; K Sato; F Tsuda; Y Miyakawa
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

View more
  15 in total

1.  Recent advances in laboratory diagnosis of hepatitis C virus infection.

Authors:  R Chaudhary
Journal:  Can J Infect Dis       Date:  1994-11

2.  Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.

Authors:  S Le Pogam; F Dubois; R Christen; C Raby; A Cavicchini; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Distribution of hepatitis C virus genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System.

Authors:  R Chaudhary; M Tepper; S Eisaadany; P R Gully
Journal:  Can J Infect Dis       Date:  1999-01

4.  cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C.

Authors:  C B O'Brien; B S Henzel; L Wolfe; K Gutekunst; D Moonka
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

5.  Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.

Authors:  M Schröter; H H Feucht; P Schäfer; B Zöllner; R Laufs
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Second-generation line probe assay for hepatitis C virus genotyping.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Hernandez; G Maertens
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes.

Authors:  Matthias Schröter; Bernhard Zöllner; Peter Schäfer; Olfert Landt; Ulrich Lass; Rainer Laufs; Heinz-Hubert Feucht
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.

Authors:  Johannes Vermehren; Annika Kau; Barbara C Gärtner; Reinhild Göbel; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

9.  Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.

Authors:  Jannick Verbeeck; Mark J Stanley; Jen Shieh; Linda Celis; Els Huyck; Elke Wollants; Judy Morimoto; Alice Farrior; Erwin Sablon; Margaret Jankowski-Hennig; Carl Schaper; Pamela Johnson; Marc Van Ranst; Marianne Van Brussel
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

10.  HCV genotypes in patients with chronic hepatitis C in Croatia.

Authors:  A Vince; D Palmović; N Kutela; Z Sonicky; T Jeren; M Radovani
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.